Arcadia Biosciences (RKDA) Current Assets (2014 - 2025)

Arcadia Biosciences has reported Current Assets for 12 years, with the latest figure at $6.4 million in Q4 2025.

• For the quarter ending Q4 2025, Current Assets fell 31.23% year-over-year to $6.4 million; the trailing twelve-month figure through Dec 2025 stood at $6.4 million (down 31.23% YoY), and the FY2025 full-year result was $6.4 million, down 31.23% from the prior year.
• Current Assets for Q4 2025 stood at $6.4 million, down from $8.4 million in the prior quarter.
• The five-year high for Current Assets was $56.6 million in Q1 2021, with the low at $6.4 million in Q4 2025.
• Historically, Current Assets has averaged $23.2 million across 5 years, with a median of $21.7 million in 2023.
• Annual changes were most pronounced in 2021 — Current Assets jumped 138.29% — and 2024, when it slumped 57.21%.
• Arcadia Biosciences' Current Assets stood at $35.4 million in 2021, then decreased by 28.23% to $25.4 million in 2022, then tumbled by 41.05% to $15.0 million in 2023, then tumbled by 38.27% to $9.2 million in 2024, then tumbled by 31.23% to $6.4 million in 2025.
• The last three Current Assets figures came in at $6.4 million (Q4 2025), $8.4 million (Q3 2025), and $7.6 million (Q2 2025), per Business Quant data.